- Investing Ideas
- /
- German Pharmaceuticals & Biotech Top Stock Picks from Analysts
German Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
8
Companies which are more than 50% undervalued based on analyst price target.
8 companies
Gerresheimer
Market Cap: €1.2b
Provides medicine packaging, drug delivery devices, and solutions in Germany and internationally.
GXI
€34.66
7D
-19.5%
1Y
-56.7%
Evotec
Market Cap: €1.1b
Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.
EVT
€5.93
7D
-6.3%
1Y
-7.7%
Formycon
Market Cap: €390.4m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€22.10
7D
-4.1%
1Y
-59.4%
Heidelberg Pharma
Market Cap: €137.0m
A biopharmaceutical company, focuses on oncology and antibody targeted amanitin conjugates (ATAC) in Germany, the United States, and internationally.
HPHA
€2.94
7D
-16.2%
1Y
23.0%
MPH Health Care
Market Cap: €76.2m
An investment company, engages in the healthcare business in Germany.
93M1
€17.80
7D
-5.3%
1Y
-24.6%
Cantourage Group
Market Cap: €48.5m
Operates as a medical cannabis company in Europe.
HIGH
€3.89
7D
9.9%
1Y
-23.0%
Vidac Pharma Holding
Market Cap: €23.2m
An investment holding company, engages in the discovery and development of medicines for oncologic and dermatologic diseases.
T9G
€0.45
7D
-3.8%
1Y
32.4%
SynBiotic
Market Cap: €19.9m
Engages in the research and development, production, and marketing of cannabinoid and terpene-based solutions to for pain, sleep deprivation, and anxiety.
SBX
€2.93
7D
0%
1Y
-51.7%